LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹29 Cr | ₹32 Cr | ₹57 Cr | ₹82 Cr | ₹69 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LAURUS LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹29 Cr |
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹82 Cr |
| Mar2022 | ₹69 Cr |
How is Deferred Tax Assets / Liabilities of LAURUS LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹29 Cr | -7.81 | |
| Mar2025 | ₹32 Cr | -44.13 | |
| Mar2024 | ₹57 Cr | -30.82 | |
| Mar2023 | ₹82 Cr | 19.30 | |
| Mar2022 | ₹69 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹99,172.1 Cr | 3% | 20% | 103.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3% |
20% |
103.8% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses